Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,061,008
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
7,046,307
-
Shares change
-
-6,254
-
Total reported value, excl. options
-
$17,074,708
-
Value change
-
-$15,992
-
Number of buys
-
2
-
Number of sells
-
-4
-
Price
-
$2.42
Significant Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2022
13 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q4 2022.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,046,307 shares
of 41,061,008 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include 22NW, LP (5,066,290 shares), LVW Advisors, LLC (673,914 shares), Nantahala Capital Management, LLC (511,073 shares), MANGROVE PARTNERS (399,219 shares), Praetorian Capital Management LLC (180,005 shares), Ikarian Capital, LLC (156,203 shares), Herr Investment Group LLC (29,644 shares), BOOTHBAY FUND MANAGEMENT, LLC (17,319 shares), BlackRock Inc. (7,293 shares), and Tower Research Capital LLC (TRC) (3,597 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.